Bellows Capital Partners is a leading investment firm offering a differentiated approach to healthcare investments that focuses on products, technologies, and global businesses that advance healthcare outcomes and deliver superior value to all stakeholders. Bellows Capital invests in therapeutic (pharmaceutical, biological, etc.) and medical device products and technologies utilizing a wide variety of investment structures. Bellows produces investment decisions driven by fundamental analyses derived from scientific, commercial, regulatory, and financial risks. The Bellows Capital team’s combination of clinical, operational, legal, regulatory, and financial experience allows the firm to identify, execute, and realize investments across the healthcare industry, particularly focused on the specialty and generic therapeutic, as well as the diagnostic, medical, and information technology sectors.